Literature DB >> 22856198

Study of nebulization delivery of aerosolized fluorescent microspheres to the avian respiratory tract.

Lisa A Tell1, Kimberly Stephens, Stephen V Teague, Kent E Pinkerton, Otto G Raabe.   

Abstract

This study investigated the delivery of an aerosol of monodisperse microspheres to the respiratory tract of birds following aerosol exposure. Adult domestic pigeons (Columbia livia domestica, n = 5 birds per timed treatment) were exposed to an aerosol of fluorescent 1.0 microm diameter carboxylate microspheres for 0.5, 1, 2, or 4 hr. During the aerosolization period, the birds were free-standing in a plexiglass treatment chamber and the aerosol was delivered using a commercial nebulizer. Immediately following aerosol exposure, the birds were euthanatized and the carcasses were intravenously infused with a modified paraformaldehyde/gluteraldehyde fixative. Evaluation of microsphere distribution was performed using a stereoscopic microscope with an epifluorescent module. The results from this study revealed that the amount of aerosolized particles delivered using a commercial nebulizer was proportional to exposure periods. Aerosol exposure periods of 0.5 hr or 1 hr did not result in a readily observable distribution of 1.0 microm fluorescent microspheres to the cranial thoracic, caudal thoracic, or abdominal air sac membranes. This was partly attributed to the relatively low concentration of the individual monodisperse microspheres in the aerosolized suspension. The 2- and 4-hr exposure periods resulted in readily observable deposition of the 1.0 mirom fluorescent microspheres in the cranial thoracic, caudal thoracic, or abdominal air sac membranes, with the 4-hr exposure period resulting in the greatest number of particles on the membrane surfaces. For each of the exposure periods, there was individual animal variation regarding the distribution and relative number of spheres deposited. This study demonstrates the widespread deposition of particles that had an aerodynamic equivalent diameter of approximately 1 microm and provides a better understanding of particle deposition efficiency within the respiratory system following aerosol exposure in birds.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22856198      PMCID: PMC4451201          DOI: 10.1637/9989-111511-Reg.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  22 in total

Review 1.  Comparative respiratory morphology: themes and principles in the design and construction of the gas exchangers.

Authors:  J N Maina
Journal:  Anat Rec       Date:  2000-02-15

Review 2.  Relationship of structure and function of the avian respiratory system to disease susceptibility.

Authors:  M R Fedde
Journal:  Poult Sci       Date:  1998-08       Impact factor: 3.352

3.  Airborne-particle deposition in the respiratory tract of chickens.

Authors:  R B Hayter; E L Besch
Journal:  Poult Sci       Date:  1974-07       Impact factor: 3.352

4.  The dilution of monodisperse suspensions for aerosolization.

Authors:  O G Raabe
Journal:  Am Ind Hyg Assoc J       Date:  1968 Sep-Oct

5.  Comparison of twenty three nebulizer/compressor combinations for domiciliary use.

Authors:  E C Smith; J Denyer; A H Kendrick
Journal:  Eur Respir J       Date:  1995-07       Impact factor: 16.671

6.  Fabrication and use of krypton-85 aerosol discharge devices.

Authors:  S V Teague; H C Yeh; G J Newton
Journal:  Health Phys       Date:  1978-08       Impact factor: 1.316

7.  Aerosol vaccination against Newcastle disease: virus levels in different organs.

Authors:  H Yadin
Journal:  Zentralbl Veterinarmed B       Date:  1981

Review 8.  Aerosol therapy in the equine species.

Authors:  D H Duvivier; D Votion; S Vandenput; P Lekeux
Journal:  Vet J       Date:  1997-11       Impact factor: 2.688

9.  Mycoplasma gallisepticum as a model to assess efficacy of inhalant therapy in budgerigars (Melopsittacus undulatus).

Authors:  M B Brown; G D Butcher
Journal:  Avian Dis       Date:  1991 Oct-Dec       Impact factor: 1.577

10.  Continuous nebulization therapy for asthma with aerosols of beta2 agonists.

Authors:  O G Raabe; T M Wong; G B Wong; J W Roxburgh; S D Piper; J I Lee
Journal:  Ann Allergy Asthma Immunol       Date:  1998-06       Impact factor: 6.347

View more
  2 in total

Review 1.  Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.

Authors:  Daniella Calderon-Nieva; Kalhari Bandara Goonewardene; Susantha Gomis; Marianna Foldvari
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

2.  Aerosol delivery of synthetic DNA containing CpG motifs in broiler chicks at hatch under field conditions using a commercial-scale prototype nebulizer provided protection against lethal Escherichia coli septicemia.

Authors:  K B Goonewardene; S Popowich; S Gebhardt; T Gunawardana; A Gupta; S Kurukulasuriya; R Karunarathna; M Liu; B Chow-Lockerbie; L Ayalew; K A Ahmed; Houman Kamali; S K Tikoo; M Foldvari; P Willson; J Boire; K Roberts; N Ambrose; C Simonson; S Gomis
Journal:  Poult Sci       Date:  2020-12-24       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.